Search by Drug Name or NDC
NDC 00067-3998-30 Lamisil 10 mg/g Details
Lamisil 10 mg/g
Lamisil is a TOPICAL CREAM in the HUMAN OTC DRUG category. It is labeled and distributed by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. The primary component is TERBINAFINE HYDROCHLORIDE.
Product Information
NDC | 00067-3998 |
---|---|
Product ID | 0067-3998_f4438d90-0dcc-40ee-92a7-bdceb17ef010 |
Associated GPIs | 90150087103710 |
GCN Sequence Number | 018273 |
GCN Sequence Number Description | terbinafine HCl CREAM (G) 1 % TOPICAL |
HIC3 | Q5F |
HIC3 Description | TOPICAL ANTIFUNGALS |
GCN | 62498 |
HICL Sequence Number | 007590 |
HICL Sequence Number Description | TERBINAFINE HCL |
Brand/Generic | Brand |
Proprietary Name | Lamisil |
Proprietary Name Suffix | AT |
Non-Proprietary Name | TERBINAFINE HYDROCHLORIDE |
Product Type | HUMAN OTC DRUG |
Dosage Form | CREAM |
Route | TOPICAL |
Active Ingredient Strength | 10 |
Active Ingredient Units | mg/g |
Substance Name | TERBINAFINE HYDROCHLORIDE |
Labeler Name | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
Pharmaceutical Class | Allylamine Antifungal [EPC], Allylamine [CS] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA020980 |
Listing Certified Through | 2024-12-31 |
Package
Package Images

NDC 00067-3998-30 (00067399830)
NDC Package Code | 0067-3998-30 |
---|---|
Billing NDC | 00067399830 |
Package | 1 TUBE in 1 CARTON (0067-3998-30) / 30 g in 1 TUBE |
Marketing Start Date | 2005-08-10 |
NDC Exclude Flag | N |
Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL de5def4a-f77f-4ea6-a497-24f041c1f123 Details
Uses
Keep out of reach of children
Directions
• adults and children 12 years and over:
• use the tip of the cap to break the seal and open the tube
• wash the affected skin with soap and water and dry completely before applying
• for athlete’s foot wear well-fitting, ventilated shoes. Change shoes and socks at least once daily
• between the toes only: apply twice a day (morning and night) for 1 week or as directed by a doctor
1 week between the toes
• on the bottom or sides of the foot: apply twice a day (morning and night) for 2 weeks or as directed by a doctor
2 weeks on the bottom or sides of the foot
• for jock itch and ringworm: apply once a day (morning or night) for 1 week or as directed by a doctor
• wash hands after each use
• children under 12 years: ask a doctor
Other information
Inactive ingredients
Questions or comments?
Principal display panel
INGREDIENTS AND APPEARANCE
LAMISIL
AT
terbinafine hydrochloride cream |
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
Labeler - GlaxoSmithKline Consumer Healthcare Holdings (US) LLC (079944263) |